You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: RE39861


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE39861
Title:Methods of extended use oral contraception
Abstract:A method of female contraception involves administering a combination of estrogen and progestin for 60-110 consecutive days in which the daily amounts of estrogen and progestin are equivalent to about 5-35 mcg of ethinyl estradiol and about 0.025 to 10 mg of norethindrone acetate, respectively. The advantages include less menstrual bleeding, less patient anemia, less total exposure to medication, higher compliance rates and more lifestyle convenience for patients.
Inventor(s): Hodgen; Gary D. (Virginia Beach, VA)
Assignee: Duramed Pharmaceuticals, Inc. (Pomona, NY)
Application Number:10/893,795
Patent Claim Types:
see list of patent claims
Use; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent RE39861: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This article will delve into the specifics of United States Patent RE39861, exploring its claims, the patent landscape, and the implications for stakeholders.

Understanding Patent Claims

Patent claims are the most critical part of any patent application, as they define the scope of the invention and what is protected by the patent. Claims can be categorized into independent and dependent claims, each serving a distinct purpose[3].

Overview of United States Patent RE39861

Patent Title and Abstract

United States Patent RE39861, though not specifically detailed in the provided sources, would typically involve a title and abstract that summarize the invention. The title provides a concise description, while the abstract gives a brief overview of the invention, including its purpose and key features[4].

Background and Description

The patent would include a detailed background of the invention, explaining the problem it solves and the state of the art at the time of filing. The description section would provide a comprehensive explanation of the invention, including drawings and detailed specifications necessary for someone skilled in the art to replicate the invention[4].

Claims Analysis

Independent Claims

Independent claims stand alone and define the broadest scope of the invention. These claims are crucial as they set the boundaries of what is considered novel and non-obvious. For example, if RE39861 pertains to a technological innovation, the independent claims would outline the core components and their interactions[3].

Dependent Claims

Dependent claims build upon the independent claims, adding specific limitations or features that narrow the scope. These claims are often used to protect variations or specific embodiments of the invention. Analyzing dependent claims helps in understanding the various aspects of the invention and how they contribute to its overall functionality[3].

Patent Landscape Analysis

Claim Coverage Matrix

To understand the patent landscape surrounding RE39861, a Claim Coverage Matrix can be used. This tool categorizes patents by claims and scope concepts, helping to identify which patents and claims are actively protecting the intellectual property. It also highlights gaps or opportunities in the current coverage[3].

Scope Concepts and Claim Charts

Scope concepts link claims on similar patents, providing a powerful categorization tool for filtering and searching large numbers of patent claims. Interactive claim charts generated by tools like ClaimScape® can be reviewed by technical experts to determine the applicability of a particular scope concept to a target product or method. This helps in identifying areas where claim coverage is lacking and highlights future design opportunities[3].

Patent Eligibility and Jurisprudence

Alice/Mayo Framework

The patent eligibility of RE39861 would be evaluated under the Alice/Mayo framework, which is a two-step test established by the Supreme Court. The first step determines if the patent claims are directed to an ineligible concept (e.g., laws of nature, natural phenomena, or abstract ideas). If they are, the second step assesses whether the claims contain an inventive concept that transforms the nature of the claim into a patent-eligible application[2].

Recent Developments in Patent Eligibility

Recent guidance from the USPTO, such as the 2019 Guidance, has clarified how to apply the Alice/Mayo framework, particularly for computer-related inventions. This guidance has lowered Section 101 barriers to patentability, potentially affecting the eligibility of patents like RE39861[2].

Geographic and Technological Trends

Global Patenting Trends

Analyzing global patenting trends involves considering time, technology, and country elements. Patents are classified under WIPO’s International Patent Classification (IPC) system, which helps in understanding the technological areas in which the patent is categorized. The country assigned to a PCT application is based on the priority country, which is the country of the earliest priority document in the patent family[1].

U.S. County-Level Data

For patents filed in the United States, county-level data can provide insights into regional innovation trends. This data includes total patents, patents by technical field, and unassigned patents, enabling analyses of patterns and trends in patenting activity across different regions[1].

Expedited Examination and Costs

Expedited Examination Programs

For patents like RE39861, expedited examination programs such as Accelerated Examination and Track One Prioritized Examination can reduce the examination time significantly. These programs have different requirements and fees, with Track One being more popular due to its simplicity and faster turnaround time[4].

Official Fees and Entity Status

The official fees for patent filings vary based on the submitting organization’s size and the type of patent. Small entities (non-profits or companies with less than 500 employees) and micro entities (meeting additional income and application requirements) benefit from reduced fees[4].

Key Takeaways

  • Patent Claims: Understanding the independent and dependent claims is crucial for defining the scope of the invention.
  • Patent Landscape: Using tools like Claim Coverage Matrix and scope concepts helps in analyzing the patent landscape and identifying gaps or opportunities.
  • Patent Eligibility: The Alice/Mayo framework is essential for determining the patent eligibility of inventions, especially in areas like computer software and biotechnology.
  • Geographic and Technological Trends: Analyzing global and regional patenting trends provides insights into innovation patterns and technological advancements.
  • Expedited Examination: Expedited examination programs can significantly reduce the time and cost associated with patent filings.

FAQs

What is the purpose of independent claims in a patent?

Independent claims define the broadest scope of the invention and set the boundaries of what is considered novel and non-obvious.

How does the Alice/Mayo framework affect patent eligibility?

The Alice/Mayo framework is a two-step test that determines if patent claims are directed to an ineligible concept and if they contain an inventive concept that transforms the nature of the claim.

What is the difference between Accelerated Examination and Track One Prioritized Examination?

Accelerated Examination requires a prior art search and a petition, while Track One Prioritized Examination does not have special requirements but carries a higher fee for priority examination.

How do small and micro entities benefit from patent filing fees?

Small and micro entities benefit from reduced official fees, with micro entities receiving an additional reduction if they meet specific income and application requirements.

What is the role of scope concepts in patent analytics?

Scope concepts link claims on similar patents, providing a powerful categorization tool for filtering, searching, and analyzing large numbers of patent claims to identify gaps or opportunities in the current coverage.

Sources

  1. Invention, Knowledge Transfer, and Innovation - National Science Foundation.
  2. Patent-Eligible Subject Matter Reform: An Overview - Congressional Research Service.
  3. Patent Analytics - Schwegman Lundberg & Woessner.
  4. TIMELINE AND COSTS FOR PATENT FILINGS - Small Business Innovation Research (SBIR).

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE39861

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.